About
Sim&Cure is a digital Medtech startup founded in 2014 and based in Montpellier, France. The company specializes in enhancing patient outcomes and physician experiences in endovascular treatments, particularly for cerebral aneurysms. Utilizing advanced technologies like Digital Twin and Artificial Intelligence, Sim&Cure improves therapeutic planning and decision-making in neurovascular interventions. The flagship product, Sim&Size®, is a medical software that optimizes the selection of endovascular devices for brain aneurysm treatment. It allows healthcare professionals to model complex therapeutic strategies and visualize various treatment options. Sim&Size® has been utilized in over 20,000 neurovascular procedures across more than 40 countries, demonstrating its significant impact on treatment quality. Sim&Cure emphasizes a patient-centric approach and collaborates with leading scientific laboratories and hospitals worldwide to advance treatment strategies. The company has achieved important regulatory milestones, including CE marking for Sim&Size® under the European Union's Medical Device Regulation. Sim&Cure has expanded its reach with a subsidiary in New York and plans to grow further in Asia, particularly China, in 2024.
Technologies
Keywords
Company Information
-
Employees 58
-
Founded 2014
-
Annual Revenue $4000000
-
Total Funding $3355498
Location
95 Rue Pierre Flourens, Montpellier, Occitanie, France, 34090
